Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
American Heart Journal|March 12, 2011
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stentingNikolaus Sarafoff, Lydia Neumann, Tanja Morath, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 14, 2009
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometryNicolas von Beckerath, Dirk Sibbing, Stefan Jawansky, et al.
Thrombosis and Haemostasis|August 14, 2019
Antagonizing P2Y12 Receptor Inhibitors: Current and Future OptionsDietmar Trenk, Laura Hille, Stefan Leggewie, et al.
Thrombosis and Haemostasis|January 25, 2008
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatmentDirk Sibbing, Siegmund Braun, Stefan Jawansky, et al.
Journal of the American College of Cardiology|March 7, 2009
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosisDirk Sibbing, Siegmund Braun, Tanja Morath, et al.
European Heart Journal|May 10, 2008
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary interventionDirk Sibbing, Gabriele Busch, Siegmund Braun, et al.
Thrombosis and Haemostasis|January 19, 2013
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stentingIsabell Bernlochner, Katharina Mayer, Tanja Morath, et al.
Platelets|June 8, 2012
Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelorMartin Orban, Julia Riegger, Michael Joner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarctionDirk Sibbing, Olga von Beckerath, Nicolas von Beckerath, et al.
Platelets|August 25, 2012
High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoringIsabell Bernlochner, Katharina Mayer, Tanja Morath, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
American Heart Journal|March 12, 2011
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stentingNikolaus Sarafoff, Lydia Neumann, Tanja Morath, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 14, 2009
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometryNicolas von Beckerath, Dirk Sibbing, Stefan Jawansky, et al.
Thrombosis and Haemostasis|August 14, 2019
Antagonizing P2Y12 Receptor Inhibitors: Current and Future OptionsDietmar Trenk, Laura Hille, Stefan Leggewie, et al.
Thrombosis and Haemostasis|January 25, 2008
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatmentDirk Sibbing, Siegmund Braun, Stefan Jawansky, et al.
Journal of the American College of Cardiology|March 7, 2009
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosisDirk Sibbing, Siegmund Braun, Tanja Morath, et al.
European Heart Journal|May 10, 2008
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary interventionDirk Sibbing, Gabriele Busch, Siegmund Braun, et al.
Thrombosis and Haemostasis|January 19, 2013
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stentingIsabell Bernlochner, Katharina Mayer, Tanja Morath, et al.
Platelets|June 8, 2012
Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelorMartin Orban, Julia Riegger, Michael Joner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarctionDirk Sibbing, Olga von Beckerath, Nicolas von Beckerath, et al.
Platelets|August 25, 2012
High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoringIsabell Bernlochner, Katharina Mayer, Tanja Morath, et al.
Pageof 20